Omar Albanyan

496 total citations
11 papers, 250 citations indexed

About

Omar Albanyan is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Omar Albanyan has authored 11 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Hematology and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Omar Albanyan's work include CAR-T cell therapy research (5 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). Omar Albanyan is often cited by papers focused on CAR-T cell therapy research (5 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). Omar Albanyan collaborates with scholars based in United States, Saudi Arabia and France. Omar Albanyan's co-authors include J. Mark FitzGerald, Mohammad S. Dairi, Zafar Zafarí, Javier Muñoz, Julio C. Chávez, Kai Rejeski, Jay Yang, Marion Subklewe, Lois Ayash and Yucai Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Omar Albanyan

10 papers receiving 245 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Omar Albanyan United States 6 154 143 39 16 15 11 250
Alicia Gayle United Kingdom 9 199 1.3× 107 0.7× 23 0.6× 12 0.8× 30 2.0× 24 234
Denise Modina Italy 6 282 1.8× 146 1.0× 11 0.3× 14 0.9× 40 2.7× 7 334
Sacha Macansh Australia 9 384 2.5× 181 1.3× 19 0.5× 42 2.6× 33 2.2× 18 421
Laura Labonté Canada 5 109 0.7× 43 0.3× 20 0.5× 21 1.3× 9 0.6× 12 181
S. Khan‐Wasti United Kingdom 4 122 0.8× 262 1.8× 42 1.1× 6 0.4× 13 0.9× 8 395
K.‐U. Min South Korea 10 134 0.9× 197 1.4× 9 0.2× 16 1.0× 23 1.5× 15 298
Charu Chopra United Kingdom 5 47 0.3× 93 0.7× 31 0.8× 25 1.6× 14 0.9× 13 206
Gülnür Tokuç Türkiye 8 74 0.5× 48 0.3× 23 0.6× 21 1.3× 5 0.3× 31 176
Ilonka H. van Veen Netherlands 6 325 2.1× 386 2.7× 12 0.3× 13 0.8× 15 1.0× 8 439
Sean O’Quinn United States 9 145 0.9× 138 1.0× 8 0.2× 12 0.8× 12 0.8× 21 249

Countries citing papers authored by Omar Albanyan

Since Specialization
Citations

This map shows the geographic impact of Omar Albanyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omar Albanyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omar Albanyan more than expected).

Fields of papers citing papers by Omar Albanyan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omar Albanyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omar Albanyan. The network helps show where Omar Albanyan may publish in the future.

Co-authorship network of co-authors of Omar Albanyan

This figure shows the co-authorship network connecting the top 25 collaborators of Omar Albanyan. A scholar is included among the top collaborators of Omar Albanyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omar Albanyan. Omar Albanyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
3.
Albanyan, Omar, Julio C. Chávez, & Javier Muñoz. (2022). The role of CAR-T cell therapy as second line in diffuse large B-cell lymphoma. Therapeutic Advances in Hematology. 13. 1554059271–1554059271. 8 indexed citations
4.
Crowder, Sylvia L., Laura Redwine, Michael L. Nieder, et al.. (2022). Mindfulness in Adolescent and Young Adult (AYA) Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT): A Qualitative Study. Cancers. 14(11). 2760–2760. 3 indexed citations
6.
Modi, Dipenkumar, Omar Albanyan, Seongho Kim, et al.. (2021). Grade 3–4 cytokine release syndrome is associated with poor survival in haploidentical peripheral blood stem cell transplantation. Leukemia & lymphoma. 62(8). 1982–1989. 5 indexed citations
7.
Albanyan, Omar, et al.. (2020). High Ki67 proliferation index but not cell-of-origin subtypes is associated with shorter overall survival in diffuse large B-cell lymphoma. SHILAP Revista de lepidopterología. 10(4). 241–248. 8 indexed citations
8.
Albanyan, Omar, Seongho Kim, Abhinav Deol, et al.. (2020). Incidence, Risk Factors and Outcomes of Cardiac Toxicity in Haploidentical Peripheral Stem Cell Transplantation with High Dose Cyclophosphamide. Blood. 136(Supplement 1). 35–36. 1 indexed citations
9.
Albanyan, Omar, Seongho Kim, Abhinav Deol, et al.. (2020). Grade III-IV cytokine release syndrome is associated with inferior survival in patients undergoing haploidentical donor stem cell transplants.. Journal of Clinical Oncology. 38(15_suppl). 7546–7546. 1 indexed citations
10.
Modi, Dipenkumar, Omar Albanyan, Seongho Kim, et al.. (2020). Toxicities after high dose post-transplant cyclophosphamide in haploidentical donor transplants: Risk factors and impact on survival.. Journal of Clinical Oncology. 38(15_suppl). 7545–7545. 1 indexed citations
11.
Zafarí, Zafar, et al.. (2015). Asthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta Analysis. PLoS ONE. 10(9). e0136065–e0136065. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026